NORTH ATTLEBORO, Mass., July 20, 2011 /PRNewswire/ — Medical
Device Consultants, Inc. (MDCI), a leading regulatory consulting
firm and CRO for the medical device industry, announced today that
Mr. Frederick (Fred) Tobia has joined the company as director of
regulatory and clinical services. He will oversee the daily
operations of the company’s clinical and regulatory services
groups, reporting to Vicki Anastasi, vice president of regulatory
services and business development.
Fred brings over twenty years of experience in the medical
device and CRO industry and has held increasingly senior executive
roles in regulatory, quality and clinical affairs at Alliant
Medical Technologies, Inc. (formerly UroMed), CareStat Inc., and
Seacoast Technologies. For the past six years he was vice
president, regulatory and clinical affairs at NMT Medical Inc. He
has successfully gained clearance and approval of PMAs, 510(k)s,
IDEs, INDs, NDAs, BLAs, and international Design Dossiers with and
without clinical data.
“I am excited to welcome Fred to MDCI,” said Anastasi. “His
impressive track record of integrating worldwide regulatory,
clinical and quality programs, along with a proven ability to
manage the device development process from pre-clinical through
post-market activities will serve our clients well.”
Fred holds a bachelor of science in biology from Providence
College and a certificate in public health from Harvard School of
Public Health. He has published numerous articles in
peer-reviewed journals and is a recognized speaker and advisor with
medical device industry trade and professional organizations,
including FDA task forces.
Founded in 1980, MDCI is a full-service regulatory consulting
firm and contract research organization (CRO) that helps emerging
and established firms commercialize novel and innovative medical
devices, in vitro diagnostics, and combination products.
Clients trust MDCI to deli